Analyst firms · Morgan Stanley · RPID

Morgan Stanley RPID price target and rating history

Rapid Micro Biosystems Inc. (RPID) · Health Care

Morgan Stanley rates Rapid Micro Biosystems Inc. (RPID) Equal-Weight with a $10 price target, as of its latest action on Mar 7, 2022. It has published 4 rating actions on RPID since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Equal-Weight
Price target
$10
Median target, all firms
Too few
Actions on RPID
4

Morgan Stanley price target on RPID

$26$18$1020222023202420252026
Morgan Stanley price target on RPID, each point a stated target, August 2021 to March 2022.

Every Morgan Stanley rating on RPID

Questions about Morgan Stanley and RPID

What is Morgan Stanley's price target for RPID?
Morgan Stanley's latest stated price target for Rapid Micro Biosystems Inc. (RPID) is $10, from its action on Mar 7, 2022.
What is Morgan Stanley's rating on RPID?
Morgan Stanley rates RPID Equal-Weight, a neutral rating, as of Mar 7, 2022.
When did Morgan Stanley last change its view on RPID?
On Mar 7, 2022, Morgan Stanley cuts its price target to $10 from $11, keeps Equal-Weight.

All Morgan Stanley ratingsRPID news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.